MicroRNAs in autoimmune rheumatic diseases

被引:3
|
作者
Galeazzi, M. [1 ]
Balistreri, E. [1 ]
Giannitti, C. [1 ]
Sebastiani, G. D. [2 ]
机构
[1] Univ Siena, UOC Reumatol, Dipartimento Med Clin & Sci Immunol, Siena, Italy
[2] UOC Reumatol, Azienda Osped San Camillo Forlanini, Circonvallaz Gianicolense 87, I-00152 Rome, Italy
关键词
Autoimmune diseases; epigenetics; microRNAs;
D O I
10.4081/reumatismo.2012.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology of autoimmune diseases remains largely unknown. In recent years, besides genetic factors, several studies proposed that the epigenome might hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically epigenetic regulatory mechanisms comprise DNA methylation, a variety of histone modifications, and microRNA (miRNA) activity, all of which act upon gene and protein expression levels. In particular, it is well known that epigenetic mechanisms are important for controlling the pattern of gene expression during development, the cell cycle, and the response to biological or environmental changes. In the present review a description of the most frequent epigenetic deregulations, in particular the role of miRNAs, in rheumatic autoimmune disorders will be investigated.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 50 条
  • [1] Pathogenesis and treatment of autoimmune rheumatic diseases
    Liu, Eric
    Perl, Andras
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 307 - 315
  • [2] Endothelial dysfunction in rheumatic autoimmune diseases
    Murdaca, Giuseppe
    Colombo, Barbara Maria
    Cagnati, Paola
    Gulli, Rossella
    Spano, Francesca
    Puppo, Francesco
    ATHEROSCLEROSIS, 2012, 224 (02) : 309 - 317
  • [3] Resilience in women with autoimmune rheumatic diseases
    Rojas, Manuel
    Rodriguez, Yhojan
    Pacheco, Yovana
    Zapata, Elizabeth
    Monsalve, Diana M.
    Mantilla, Ruben D.
    Rodriguez-Jimenez, Monica
    Ramirez-Santana, Carolina
    Molano-Gonzalez, Nicolas
    Anaya, Juan-Manuel
    JOINT BONE SPINE, 2018, 85 (06) : 715 - 720
  • [4] Epigenetics, pregnancy and autoimmune rheumatic diseases
    Pacini, Greta
    Paolino, Sabrina
    Andreoli, Laura
    Tincani, Angela
    Gerosa, Maria
    Caporali, Roberto
    Iagnocco, Annamaria
    Ospelt, Caroline
    Smith, Vanessa
    Cutolo, Maurizio
    AUTOIMMUNITY REVIEWS, 2020, 19 (12)
  • [5] Laboratory testing in autoimmune rheumatic diseases
    Sheldon, J
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (03): : 249 - 269
  • [6] Environment and systemic autoimmune rheumatic diseases: an overview and future directions
    Choi, May Y.
    Costenbader, Karen H.
    Fritzler, Marvin J.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] Designing studies for epigenetic biomarker development in autoimmune rheumatic diseases
    de la Calle-Fabregat, Carlos
    Rodriguez-Ubreva, Javier
    Canete, Juan D.
    Ballestar, Esteban
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2022, 3 (03): : 103 - 110
  • [8] MicroRNAs in autoimmune thyroid diseases and their role as biomarkers
    Martinez-Hernandez, Rebeca
    Marazuela, Monica
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (02)
  • [9] Rheumatic autoimmune diseases in women and midlife health
    Wendy Marder
    Évelyne Vinet
    Emily C. Somers
    Women's Midlife Health, 1 (1)
  • [10] B cell depletion in autoimmune rheumatic diseases
    Pitashny, M
    Shoenfeld, Y
    AUTOIMMUNITY REVIEWS, 2005, 4 (07) : 436 - 441